Search results
BrainStorm appoints new COO ahead of ALS study By Investing.com
Investing.com· 5 days agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a developer of adult stem cell therapies for...
The Petri Dish: Gamida emerges from bankruptcy, InduPro’s Series A investment - Boston Business...
The Business Journals· 5 days agoGamida Cell has gathered new capital as it comes out of bankruptcy, and InduPro raised a Series A....
ADC Therapeutics director Azelby sells shares worth over $20,000 By Investing.com
Investing.com· 5 days agoThe sale, which was executed to cover tax withholding obligations related to the vesting of...
Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024 -...
Benzinga· 4 days agoNavidea Biopharmaceuticals, Inc. NAVB ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will ...
3 Meme Stocks Under $10 That Will Double in 3 Months
InvestorPlace· 6 days agoEquity markets go through different levels of bullishness. There are times when blue-chips rally and growth stocks are subdued. Further, after a big...
Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically
Digital Journal· 7 days agoTORONTO, ON / ACCESSWIRE / June 18, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
3 52-Week-Low Losers Ready to Become Big-Time Stock Winners
InvestorPlace· 6 days agoBottom-picking stocks to buy is one of the most difficult strategies in trading and investing. For...
Volatus Aerospace Provides $2.4M CAD Drone and Training Package to a North American Disaster...
Digital Journal· 6 days agoSuch material factors and assumptions include, but are not limited to: the anticipated benefits and revenues of the master service agreement to the Company; the commercialization< ...
Rapidly declining costs of batteries and fuel cells could soon facilitate the electrification of...
Tech Xplore· 6 days agoThe primary reason for this is that electrifying larger and heavier vehicles is technically challenging, as powering them for long periods of time would require more expensive and sophisticated ...
Zerlasiran shows promise in phase 2 study for cardiovascular risk By Investing.com
Investing.com· 4 days agoSilence Therapeutics plc (NASDAQ:SLN), a biotech firm focusing on RNA interference (RNAi) therapies,...